Biparametric vs Multiparametric MRI for Prostate Cancer DiagnosisAlexander Ng, Sangeet Ghai, Enrique Gómez‐Gómez et al.|JAMA|2025Cited by 44
Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort studyJethro C.C. Kwong, Alexandre R. Zlotta, Adree Khondker et al.|The Lancet Digital Health|2023Cited by 16
Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have NotOtto Hemminki, Akseli Hemminki, Nathan Perlis et al.|European Urology Open Science|2020Cited by 15